PYXIS ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.81 USD | -0.26% |
|
-8.19% | +111.67% |
| 05-14 | Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M | MT |
| 05-14 | Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PYXIS ONCOLOGY, INC. | Bio Therapeutic Drugs | -0.26% | -8.19% | +111.67% | +14.07% | - | 224M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PYXS Stock
- Charts Pyxis Oncology, Inc.
- Comparison Chart
